Rachel W. Humphrey
2015
In 2015, Rachel W. Humphrey earned a total compensation of $4.8M as Chief Medical Officer at CytomX Therapeutics.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $67,423 |
| Option Awards | $4,484,838 |
| Salary | $127,885 |
| Other | $11,545 |
| Total | $4,841,691 |
Humphrey received $4.5M in option awards, accounting for 93% of the total pay in 2015.
Humphrey also received $150K in bonus, $67.4K in non-equity incentive plan, $127.9K in salary and $11.5K in other compensation.
Rankings
In 2015, Rachel W. Humphrey's compensation ranked 1,672nd out of 13,638 executives tracked by ExecPay. In other words, Humphrey earned more than 87.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,672 out of 13,638 | 88th |
Division Manufacturing | 608 out of 5,190 | 88th |
Major group Chemicals And Allied Products | 223 out of 1,854 | 88th |
Industry group Drugs | 172 out of 1,528 | 89th |
Industry Pharmaceutical Preparations | 137 out of 1,182 | 88th |
Source: SEC filing on May 9, 2017.
Humphrey's colleagues
We found three more compensation records of executives who worked with Rachel W. Humphrey at CytomX Therapeutics in 2015.